Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Formaldehyde. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL529798 | 1.00 | — | — | |
| Formaldehyde SCHEMBL16055620 | 1.00 | — | — | |
| Formaldehyde SCHEMBL27734205 | 1.00 | — | — | |
| Formaldehyde SCHEMBL2362114 | 1.00 | — | — | |
| Formaldehyde SCHEMBL3689972 | 0.89 | — | — | |
| Formaldehyde SCHEMBL11049386 | 0.89 | — | — | |
| Formaldehyde SCHEMBL10357642 | 0.89 | — | — | |
| Formaldehyde SCHEMBL27096312 | 0.89 | — | — | |
| Formaldehyde SCHEMBL6053366 | 0.89 | — | — | |
| Formaldehyde SCHEMBL27569156 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228242-A1 | PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-07-17 | — | — | US | claimed |
| CN-118495827-A | Preparation method of super-hydrophilic self-cleaning anti-fog glass | 杨梅梅 | 2024-08-16 | — | — | CN | claimed |
| CN-112142726-B | Anti-tumor drug hydrochloride hydrate crystal form | 上海汇伦医药股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117030924-A | Method for testing cation exchange capacity of hydroxyl-containing graphite oxide | 西南科技大学 | 2023-11-10 | — | — | CN | claimed |
| CN-111511730-B | Amide substituted indole compounds useful as TLR inhibitors | 百时美施贵宝公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116217392-A | Synthesis method of loxoprofen sodium key intermediate 2- (4-halomethylphenyl) propionate | 厦门医学院 | 2023-06-06 | — | — | CN | claimed |
| CN-113956142-B | Preparation method of pinacolone | 山东省科学院菏泽分院 | 2022-04-29 | — | — | CN | claimed |
| CN-113956142-A | Preparation method of pinacolone | 山东省科学院菏泽分院 | 2022-01-21 | — | — | CN | claimed |
| CN-107474119-B | Antibacterial aquaporin vesicles and preparation method and application thereof | 宁波日新恒力科技有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-106715422-B | Indene derivative, preparation method and the pharmaceutical composition for being used to prevent or treat retinal disease comprising it as active constituent | 忠南大学校产学协力团 | 2019-11-19 | — | — | CN | claimed |
| CN-101229373-A | Medicine compounds for treating diabetic nephropathy | LUNAN PHARM GROUP CORP (CN) | 2008-07-30 | — | — | CN | claimed |
| EP-1904442-A1 | HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2008-04-02 | — | — | EP | claimed |
| CN-101121004-A | Medicine composition containing insulin intensifier and miglitol | LUNAN PHARM GROUP CORP (CN) | 2008-02-13 | — | — | CN | claimed |
| CN-1939540-A | Medicine composition containing insulin sensibilizer and B-family vatamines | ANHUI MODERN CHINESE MEDICINE (CN) | 2007-04-04 | — | — | CN | claimed |
| WO-2007005503-A1 | HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-01-11 | — | — | WO | claimed |
| CN-1275886-A | Method for lowering platelet counts | LILLY CO ELI (US) | 2000-12-06 | — | — | CN | claimed |
| CN-1079239-A | Scrubbing-resistant porcelain-imitating decoration paint | ZHANG WEIMIN (CN) | 1993-12-08 | — | — | CN | claimed |
| EP-0049638-B1 | PROCESS FOR PREPARARING 5-METHYL-4-IMIDAZOLECARBOXYLIC ACID ESTERS | SMITHKLINE BECKMAN CORPORATION (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0083029-B1 | GRANULAR OR POWDERY PHENOL-ALDEHYDE RESIN AND PROCESS FOR PRODUCTION THEREOF | KANEBO, LTD. (JP) | 1986-09-03 | — | — | EP | claimed |
| EP-0049638-A1 | Process for prepararing 5-methyl-4-imidazolecarboxylic acid esters | SMITHKLINE BECKMAN CORPORATION (US) | 1982-04-14 | — | — | EP | claimed |